护心胶囊联合小剂量胺碘酮治疗房颤的临床疗效观察及对血浆心钠素水平的影响
|
摘要
目的:观察护心胶囊联合小剂量胺碘酮治疗房颤的临床疗效和安全性及对血浆心钠素水平的影响。
方法:心房纤颤患者60例随机单盲分为对照组A组,治疗组B组,各组病例数均为30例,对照组给予胺碘酮口服,治疗组给与护心胶囊联合小剂量胺碘酮,治疗3月后观察房颤转复情况及血浆心钠素的变化。
结果:
1.两组用药3个月后转复疗效情况:治疗组显效率为80%,优于对照组为66%,治疗组总有效率93.3%亦高于对照组76.6%,差异显著(P＜0.05)。
2.治疗组与对照组患者房颤发作时血浆心钠素治疗前无差别(P＞0.05);用药三月后,治疗组与对照组血浆心钠素水平相比较有显著差异(P＜0.05)。
结论:
1.护心胶囊是用于治疗心房纤颤恢复窦性心律的安全有效药物。
2.护心胶囊联合小剂量胺碘酮治疗房颤疗效明显优于单纯应用胺碘酮。护心胶囊和小剂量胺碘酮有协同作用。
3.护心胶囊联合小剂量胺碘酮能够降低心房纤颤患者血浆心钠素水平。
Objective:
To know the clinical therapeutic effects ,security and the influence on Atrialnatriuretic peptide made by using huxinjiaonang and low dose of amiodaronein the clinical study on treating patients with atrial fibrillation.Methods:
60 patients with atrial fibrillation were divided into 2 group at random by the single blind method. Each group contains 30 cases. The control group took the amiodarone in the routine method;while the treatment group took both huxinjiaonao and low dose of amiodarone.The Course of treatment was 3 month.After the treatment I assayed the patients' blood Atrial natriuretic peptide and recorded the condition of the atrial fibrillation changing into sinus rhythm,at last draw the conclusion.
Results:
(1)Three month after the treatment the effective rate of the treatment group was 80% ,while the control group was 66%,and the,well-healed rate on the treatment group was 93.3%,while the contol group was 76.6%, so the clinical effects of the treatment was better than that of the control group(P<0.05).
(2) Before treatment the blood atrial natriuretic peptide in both groups when the atrial fibrillation emerged had no significant differences(P > 0.05),but three months after the treatment the blood atrial natriuretic in both groups decreased and the treatment group had much less atrial natriuretic peptide than the control group(P<0.05).
Conclusion:
(1)Huxinjiaonang was a safe remedy in treating the patients with atrial fibrillation.
(2)Using Huxinjiaonang and low dose of amiodarone was better in treating the patients with atrial fibrillation than using amiodarone only. Huxinjiaonang and amiodarone had the effects of synergism.
(3)Huxingjiaonang can discrease the blood atrial natriuretic peptide of thepatients with atrial fibrillation.
方法:心房纤颤患者60例随机单盲分为对照组A组,治疗组B组,各组病例数均为30例,对照组给予胺碘酮口服,治疗组给与护心胶囊联合小剂量胺碘酮,治疗3月后观察房颤转复情况及血浆心钠素的变化。
结果:
1.两组用药3个月后转复疗效情况:治疗组显效率为80%,优于对照组为66%,治疗组总有效率93.3%亦高于对照组76.6%,差异显著(P＜0.05)。
2.治疗组与对照组患者房颤发作时血浆心钠素治疗前无差别(P＞0.05);用药三月后,治疗组与对照组血浆心钠素水平相比较有显著差异(P＜0.05)。
结论:
1.护心胶囊是用于治疗心房纤颤恢复窦性心律的安全有效药物。
2.护心胶囊联合小剂量胺碘酮治疗房颤疗效明显优于单纯应用胺碘酮。护心胶囊和小剂量胺碘酮有协同作用。
3.护心胶囊联合小剂量胺碘酮能够降低心房纤颤患者血浆心钠素水平。
Objective:
To know the clinical therapeutic effects ,security and the influence on Atrialnatriuretic peptide made by using huxinjiaonang and low dose of amiodaronein the clinical study on treating patients with atrial fibrillation.Methods:
60 patients with atrial fibrillation were divided into 2 group at random by the single blind method. Each group contains 30 cases. The control group took the amiodarone in the routine method;while the treatment group took both huxinjiaonao and low dose of amiodarone.The Course of treatment was 3 month.After the treatment I assayed the patients' blood Atrial natriuretic peptide and recorded the condition of the atrial fibrillation changing into sinus rhythm,at last draw the conclusion.
Results:
(1)Three month after the treatment the effective rate of the treatment group was 80% ,while the control group was 66%,and the,well-healed rate on the treatment group was 93.3%,while the contol group was 76.6%, so the clinical effects of the treatment was better than that of the control group(P<0.05).
(2) Before treatment the blood atrial natriuretic peptide in both groups when the atrial fibrillation emerged had no significant differences(P > 0.05),but three months after the treatment the blood atrial natriuretic in both groups decreased and the treatment group had much less atrial natriuretic peptide than the control group(P<0.05).
Conclusion:
(1)Huxinjiaonang was a safe remedy in treating the patients with atrial fibrillation.
(2)Using Huxinjiaonang and low dose of amiodarone was better in treating the patients with atrial fibrillation than using amiodarone only. Huxinjiaonang and amiodarone had the effects of synergism.
(3)Huxingjiaonang can discrease the blood atrial natriuretic peptide of thepatients with atrial fibrillation.
引文
[1]Benjamin EJ,Wolf PAD,Agostino RB et al.Impact of atrial fibrillation on therisk of death:the framinghan heart study.Circulation,1998,98:946-952.
[2]Upshaw CB JR.Hemodynamie changes after cardioversion of chronic atrialfibrillation.Arch Intern Med,1997,157:1070- 1076.
[3]Gocttc A,Honeycutt C,Langberg JJ.Electrial remodeling in atrialfibrillation:time course and mechanisms.Circulation,1996,94:2968-2974.
[4]杨庆祥,李小民,等.老年甲亢性房颤26例临床分析.医学临床研究,2002,19(6):444-445.
[5]陈新,张澎,胡大一,等代表中华医学会心电生理和起搏分会房性快速心律失常专家组.心房颤动:目前的认识和治疗建议.中华心律失常学杂志,2001,5(2):69-86.
[6]王利,石亚君等.老年特发性阵发性心房颤动患者的心率变异性分析.中华老年心脑血管病杂志,2003,5(4):872-874.
[7]项阳,黄峻.心房颤动的分子病因学研究.中华心律失常学杂志,2000,4:58-60.
[8]Yi-Han Chen,Came of function mutation in familial atrial fibrillation.Science,2003,299:251.
[9]Thiedemann KU,Ferran VJ.Left atrial ultrastructure in mural valvular disease.Am J Pathol,1977,89:575-604.
[10]李莹,邵建华,等.家兔快速心房起搏所致电重构和解剖重构及其时间进程的研究.中国心脏起搏与电生理杂志,2002,16:119-121.
[11]Frustaci A,Chimenti C,Bellocci F,et al.Histological substraet of atrial biopsies in patients with lone atrial fibrillation.Circulation,1997,9,337-351.
[12]郭志坤,蔡新华,等.心房颤动的细胞形态学基础-右心房的组织学观察.中国心脏起搏与心电生理杂志.1998,12:23-25.
[13]王希,黄从新,等.兔肺静脉心肌袖组织学特性研究.中华、心律失常学杂志,2003,7:241-243
[14]刘兴鹏,马长生,等.持续快速心房起搏对犬肺静脉肌袖组织结构的影响.中国心脏起搏与心电生理学杂志,2003,17:297-299.
[15]Moe GK,Rhcinboldi WC,Abildlskov,JA.A compuler model of atrial fibrillation [J].Am Heart, J, 1964; 67(2):200.
[16] Nattel S.New ideas about atrial fibrillation 50 years on [J].Nature, 2002: 415(6868):219-ZZ6
[17] Iai LP, Su 1VU, Lin JI, et al. Down-regulation of L—type calcium channel and sarcopLLSmic reticular Ca~(2+) — ATPase rnRNA in human atrial fibrillation withoudt significant change in the mRNA of ryanodine receptor, calsequestrin and phosphoLunban: an insight into the mechanism of atrial electrical remodeling [J].JAm Coll Cardiol, 1999; 33(5):1231.
[18] Ohknsa T, Ueyama T, Yamada J, et al. Alterations in cardiac sarcoplasmic reticulum Ca~(2+) regulatory proteins in the atrial tissue of patients with chronic: atrial fibrillation [J]Am Coil Cardiol, 1999: 34(1):255.
[19] Bosch RF, Zasng X, Crammer JB, et al. Ionic mechanisms of electrical remodeling in human atrial fibrillation[J].Cardiovasc Res, 1999: 44(Ⅰ):121.
[20] Kopecky Sl, GershBJ,Megoon MD,et al.The natural history of lone atrial fibrillation ; a population based study over threedecades.N Engl JMed,1987,317:669
[21] Wjiffels MC, Kirchhf CJ, Dorland R. et al. Atrial fibrillation begets atrial fibrillation:a study in awake chronically instrumented goats. Circulation, 1995,92:1954
[22] Crijns HjGM, Van Gelder IC, Gilst VAN WH, et al. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.Am J Cardiol,1991,68:335
[23] Daoud EG, Bogun F, Goyal R,et al. Effect of atrialfibrillation on atrial refractoriness in humans.Circulation,1996,94:1 600
[24] Goette A,Honeycutt C,Langberg JJ. Electrical remodeling in atrial fibrillation:Time course and mechanism. Circulation,1996,94:2 968
[25] Tieleman RG,Van Gelder IC,Grandjean JG.Recovery from electriical remodeling of the atria in patients with chronic atrial fibrillation after restoration of sinus rhythm.PACE,1997,20(pt Ⅱ):1 062
[26] 蒋文平. 心律失常用药简介. 中国心脏起搏与心电生理杂志,2001,15:361-364.
[27]陈新,张澎,胡大一,等代表中华医学会心电生理和起搏分会房性快速心律失常专家组.心房颤动:目前的认识和治疗建议.中华心律失常学杂志,2001,5(2):69-86.
[28]ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation:Executive Summary.Circulation,2001,23:2118-2144.
[29]1 Kannel WB,Abbott RD,Savage DD,et,al.Epidemiologic features of chronic atrial fibrillation:the Framingham study.N Eng J Med,1982,306:1018-1022.
[30]陈新,张澎,胡大一,等代表中华医学会心电生理和起搏分会房性快速心律失常专家组.心房颤动:目前的认识和治疗建议.中华心律失常学杂志,2001,5(2):69-86.
[31]Nathan AW,ct al Br Hcavt J 1984。52:377。
[32]Boriani G,Biffi M,Camanini C,et al.Trasveinus low energy internal cardioversion for atrial fibrillation:A review of clinical applications and future development.PACE,2001,24:99-107.
[33]刘旭,马长生.经导管心内低能量复律心房颤动.中国心脏起搏与心电生理杂志,2001,15(2):128-129.
[34]Van Hcmel Norbert M,Br HEAVT J 1994,71(2):170-177.
[35]王晓武.心房纤颤的经典迷宫术与改良迷宫术治疗.陕西医学杂志,1998,27(12):734-736.
[36]Cox JL,Ad N,Palazzo T,et al.Current status of the Maze procedure for the treatment of atrial fibrillation.Semin Thorac Cardiovasc Surg,2000,12(1):15-19.
[37]中国生物医学工程学会心脏起搏与电生理分会.中华医学会心电生理与起搏分会.射频导管消融治疗快速心律失常指南.中国心脏起搏与心电生理杂志,2002.,16(2):81-95.
[38]Neil R,Grubb,Steve Furniss ectopic.Radiofrequency ablation for atrial fibrillation..1 of British Medicine,2001,322:777-780.
[39]马长生,杨延宗,等.阵发性心房颤动局灶性消融治疗的方法学.中国心脏起搏和心电生理杂志,2000,14(1):57-66.
[40]Crijns HJ,Van GWH,et al.Serial antiarrhythmia drug treatment to maintainsinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.Am J Cardiol,1991,68:335-341.
[41]Jung W,Luderitz B.Atrial defibrillation.Z Kardiol,2000,89:206-214.
[42]沈发荣,郑良荣,徐耕,等.现代心脏起搏治疗学.上海科学技术出版社,2004,141.)
[43]Li Renli,Yao Jihua.Analysis of atrial fibrillation after implanation of VVIpacemaker-long-term observation of 154 patients.J Tongji Medicine University,2000,20(2):139-140.
[44]中国中医药学会中医诊断专业委员会.中医病证治法术语.1997.
[45]毛静远,王恒和.心房颤动中医药治疗研究述要.中医学学刊,2003,2(8):1367-1368.
[46]戚文航。心房纤颤机础研究和临床治疗新关点(J).中华心血管杂志,2002,30(10);577
[47]梁金凤贾蕾等。中医辩治冠心病合并阵发性房颤初探。陕西中医,2001,22(8)447-448
[48]伏新顺。复律汤合参麦注射液治疗房颤96例(J).辽宁中医杂志,2000,27(2):71
[49]杨关林,陈民,赵宏阳。应用转律汤辩证治疗房颤120例一附西药对照组60例(J).辽宁中医杂志,2001,21(3):17 178。
[50]谭维富复律汤治疗心房颤动28例(J),湖北中医杂志,2000,2(6):17。
[51]李宜方.中西医结合治疗风心病合并慢性心房颤动20例.山东中医杂志,1996,(6):267.
[52]梁忠.针刺宁心汤并用治疗心房颤动65例.中医函授通讯.2000,19(6):60-64.
[53]杨关林,陈民,赵父月旧.应用转复汤辨证治疗房颤120例一附西药对照组60例.辽宁中医杂志,2001(3):177-178.
[54]曲家珍,陈民,于艳萍.中医药治疗心房颤动的临床研究进展.辽宁中医杂志,1998,2(11):544.
[55]袁云成,傅延林,等.心房颤动的阴阳分类浅析.中医药学刊,2001,19(4):347.
[56]关洪峰。加味炙甘草汤对心力衰竭病发房颤的心律转复疗效观察。中国中医急症,2004,13(2):94
[57]许业辉。生脉散加味治疗老年人心房颤动15例(J)新中医,1998,30(8):62
[58]刘军,高宪虹.定心汤加味治疗快速型心律失常60例[J].上海中医药杂志,2000,34(2):23-24.。
[59]曹崇玉自拟方除颤汤治疗快速型房颤60例(J)安徽中医临床杂志。1999,11(6):395
[60]李平平,段红丽,郭宣誓,等。益气复脉法加胺碘酮治疗老年非瓣膜房颤[J].陕西中医。2006,27(2):154-155。
[61]黄惠芝,范林香.补虚化瘀重镇法为主治疗老年病因不明性房颤.实用医学杂志,1999,15(7):596.
[62]杨发荣.中药转律汤治疗快速房颤32例.辽宁中医杂志,1997,24(2):68.
[63]洪燕.参芪片对老年阵发性孤立性房颤复发的影响.现代中西医结合杂志,2003,12(6):569-571
[64]张苗青.中西医结合治疗冠心病心律失常87例临床疗效观察(J),新中医,1998,(2);21
[65]刘建民.中药抗栓合剂预防房颤复律时栓塞并发症的临床疗效观察,中国中医药信息杂志,2002,9(6):45。
[66]杨志新.心安宁滴鼻剂治疗持续性房颤临床观察.河南中医学院学报,2003,2(1):42-43
[67]张从道,针刺治疗房颤92例。上海中医杂志,1997,6(6):9
[68]张兴凯,张作鹏,冯菁,等.步长稳心颗粒与倍他乐克联合治疗阵发性心房纤颤的临床观察中国临床医药研究杂志,2006,156:18-19
[69]陈平娥.中西医结合治疗冠状动脉粥样硬化性心脏病心房颤动116例临床观察.中西医结合实用临床急救.1999,6(3):124-125.
[70]章平富.中西医结合治疗冠心病初发房颤体会.浙江中西医结合杂志.2002,12(4):242-243.
[71]苑立军,王继军.参麦注射液合胺碘酮治疗老年人冠心病心房颤动.浙江中西医结合杂志,2004,14(7):411-412.
[72]李洪珍等人参根皂贰对不同年龄大鼠单胺类递质含量和MAO活性影响的研究老年学杂志,1989;9(2):114
[73]魏群,周萍.参麦注射液治疗充血性心力衰竭50例中国中西医结合杂志,2000;(10):30
[74]韩铃 陈可冀 黄芪对心血管系统作用的实验药理研究进展中西医结合杂志,2000,20(3):234
[75]高学敏主编中药学人民卫生出版社 2000;(11):922
[76]梅全喜.现代中药药理手册[M].中国中医药出版社(第一版),1998:26-27
[77]陈红.甘草药理作用概述[J].海峡药学 2005;4(17):37-41。
[78]冉瑞明 邵平 参麦注射液治疗病毒性心肌炎107例临床观察临床荟萃,2001:(16):13
[79]李韬,曲德英,雷菠等.三七粉对[家兔实验性动脉粥样硬化的影响[J].中医研究,2006;19(1):17
[80]胡婷 中国生化药物杂志 1993;(1):53
[81]林均明 中国海洋杂志 1991,10(40):23
[82]刘青云.中药药理学[M].人民卫生出版社(第二版),2002:277。
[83]郑有顺.中医血药药理与应用[J].军事医学科学出版社,1999:128。
[84]王彬尧,占振铨,李修阳,等.心脏病治疗学.北京:中国医药科技出版社,2000.44.。
[85]Diringer MN,Kirsch JR,Ladenson PW,et al.Cerebrospinal fluid atrialnatriuretic factor in intracranial disease[J].Stroke,1990,21(11):1550-4.
[86]Nakamura S.Effect of chronic central alpha-hANP administration on blood pressure,water and electrolyte balance in rats[J].Nippon Jinzo Gakkai Shi,1993,35(4):343-347.
[87]Mckay MK,Huxley VH.ANP increases capillary permeability to protein independent of perfusate protein composition[J].Am J Physiol,1995,268(3):1139-1148.
[88]Tanakal.Atrial natriuretic factor in rat hypothalamus,atria and plasma.Detemination by specific radioimmunoassay[J].Biochem Biophys Res Commun,1984,1 24:663-666.
[89]Kawata M.Atrial natriuretic polypeptide:Topographical distribution in the rat brain by radioimmunoassay and immunchistochemistry[J].Neuroscience,1985 16:521-523.
[90]Olivera W,Ridge K,Wood LD,et al.ANF decreases active sodium transport and increases alveolar epithelial permeability in rats[J].Appl Fhysiol,1993,75(4):1581-1586.
[91]Globis S,Frank H,Pacher B,et al.Atrial natriuretic peptide release is more dependent on atrial filling volume than filling pressure in chronic congestive heart failure[J].Am Heart J,1998,135:592-597.
[92]Globis S,FrankH,Pacher B,et al Atrial natriuretic peptide release ismore dependenton atrial filling volume than filling pressure in chronic congestive heart failure[J].Am Heart J,1998,135:592-597.
[93]Verma S,Wang CH,Li SH,et al C-reactive protein attenuates nitric oxide production and inhibits angiogene-sis[J].Circulation,2002,106:913-919.
[94]FumikiY,ToshioN,Yoshikado S,et al Plasma atrial natriuretic peptide concentration inversely correlates with left atrial collagen volume fraction in patients with atrial fibrillation[J].JACC,2002,39:288-294.
[95]张晓文.心房利钠肽与“心”的关系探讨.甘肃中医学院学报,1996;13(2):5-7
[2]Upshaw CB JR.Hemodynamie changes after cardioversion of chronic atrialfibrillation.Arch Intern Med,1997,157:1070- 1076.
[3]Gocttc A,Honeycutt C,Langberg JJ.Electrial remodeling in atrialfibrillation:time course and mechanisms.Circulation,1996,94:2968-2974.
[4]杨庆祥,李小民,等.老年甲亢性房颤26例临床分析.医学临床研究,2002,19(6):444-445.
[5]陈新,张澎,胡大一,等代表中华医学会心电生理和起搏分会房性快速心律失常专家组.心房颤动:目前的认识和治疗建议.中华心律失常学杂志,2001,5(2):69-86.
[6]王利,石亚君等.老年特发性阵发性心房颤动患者的心率变异性分析.中华老年心脑血管病杂志,2003,5(4):872-874.
[7]项阳,黄峻.心房颤动的分子病因学研究.中华心律失常学杂志,2000,4:58-60.
[8]Yi-Han Chen,Came of function mutation in familial atrial fibrillation.Science,2003,299:251.
[9]Thiedemann KU,Ferran VJ.Left atrial ultrastructure in mural valvular disease.Am J Pathol,1977,89:575-604.
[10]李莹,邵建华,等.家兔快速心房起搏所致电重构和解剖重构及其时间进程的研究.中国心脏起搏与电生理杂志,2002,16:119-121.
[11]Frustaci A,Chimenti C,Bellocci F,et al.Histological substraet of atrial biopsies in patients with lone atrial fibrillation.Circulation,1997,9,337-351.
[12]郭志坤,蔡新华,等.心房颤动的细胞形态学基础-右心房的组织学观察.中国心脏起搏与心电生理杂志.1998,12:23-25.
[13]王希,黄从新,等.兔肺静脉心肌袖组织学特性研究.中华、心律失常学杂志,2003,7:241-243
[14]刘兴鹏,马长生,等.持续快速心房起搏对犬肺静脉肌袖组织结构的影响.中国心脏起搏与心电生理学杂志,2003,17:297-299.
[15]Moe GK,Rhcinboldi WC,Abildlskov,JA.A compuler model of atrial fibrillation [J].Am Heart, J, 1964; 67(2):200.
[16] Nattel S.New ideas about atrial fibrillation 50 years on [J].Nature, 2002: 415(6868):219-ZZ6
[17] Iai LP, Su 1VU, Lin JI, et al. Down-regulation of L—type calcium channel and sarcopLLSmic reticular Ca~(2+) — ATPase rnRNA in human atrial fibrillation withoudt significant change in the mRNA of ryanodine receptor, calsequestrin and phosphoLunban: an insight into the mechanism of atrial electrical remodeling [J].JAm Coll Cardiol, 1999; 33(5):1231.
[18] Ohknsa T, Ueyama T, Yamada J, et al. Alterations in cardiac sarcoplasmic reticulum Ca~(2+) regulatory proteins in the atrial tissue of patients with chronic: atrial fibrillation [J]Am Coil Cardiol, 1999: 34(1):255.
[19] Bosch RF, Zasng X, Crammer JB, et al. Ionic mechanisms of electrical remodeling in human atrial fibrillation[J].Cardiovasc Res, 1999: 44(Ⅰ):121.
[20] Kopecky Sl, GershBJ,Megoon MD,et al.The natural history of lone atrial fibrillation ; a population based study over threedecades.N Engl JMed,1987,317:669
[21] Wjiffels MC, Kirchhf CJ, Dorland R. et al. Atrial fibrillation begets atrial fibrillation:a study in awake chronically instrumented goats. Circulation, 1995,92:1954
[22] Crijns HjGM, Van Gelder IC, Gilst VAN WH, et al. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.Am J Cardiol,1991,68:335
[23] Daoud EG, Bogun F, Goyal R,et al. Effect of atrialfibrillation on atrial refractoriness in humans.Circulation,1996,94:1 600
[24] Goette A,Honeycutt C,Langberg JJ. Electrical remodeling in atrial fibrillation:Time course and mechanism. Circulation,1996,94:2 968
[25] Tieleman RG,Van Gelder IC,Grandjean JG.Recovery from electriical remodeling of the atria in patients with chronic atrial fibrillation after restoration of sinus rhythm.PACE,1997,20(pt Ⅱ):1 062
[26] 蒋文平. 心律失常用药简介. 中国心脏起搏与心电生理杂志,2001,15:361-364.
[27]陈新,张澎,胡大一,等代表中华医学会心电生理和起搏分会房性快速心律失常专家组.心房颤动:目前的认识和治疗建议.中华心律失常学杂志,2001,5(2):69-86.
[28]ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation:Executive Summary.Circulation,2001,23:2118-2144.
[29]1 Kannel WB,Abbott RD,Savage DD,et,al.Epidemiologic features of chronic atrial fibrillation:the Framingham study.N Eng J Med,1982,306:1018-1022.
[30]陈新,张澎,胡大一,等代表中华医学会心电生理和起搏分会房性快速心律失常专家组.心房颤动:目前的认识和治疗建议.中华心律失常学杂志,2001,5(2):69-86.
[31]Nathan AW,ct al Br Hcavt J 1984。52:377。
[32]Boriani G,Biffi M,Camanini C,et al.Trasveinus low energy internal cardioversion for atrial fibrillation:A review of clinical applications and future development.PACE,2001,24:99-107.
[33]刘旭,马长生.经导管心内低能量复律心房颤动.中国心脏起搏与心电生理杂志,2001,15(2):128-129.
[34]Van Hcmel Norbert M,Br HEAVT J 1994,71(2):170-177.
[35]王晓武.心房纤颤的经典迷宫术与改良迷宫术治疗.陕西医学杂志,1998,27(12):734-736.
[36]Cox JL,Ad N,Palazzo T,et al.Current status of the Maze procedure for the treatment of atrial fibrillation.Semin Thorac Cardiovasc Surg,2000,12(1):15-19.
[37]中国生物医学工程学会心脏起搏与电生理分会.中华医学会心电生理与起搏分会.射频导管消融治疗快速心律失常指南.中国心脏起搏与心电生理杂志,2002.,16(2):81-95.
[38]Neil R,Grubb,Steve Furniss ectopic.Radiofrequency ablation for atrial fibrillation..1 of British Medicine,2001,322:777-780.
[39]马长生,杨延宗,等.阵发性心房颤动局灶性消融治疗的方法学.中国心脏起搏和心电生理杂志,2000,14(1):57-66.
[40]Crijns HJ,Van GWH,et al.Serial antiarrhythmia drug treatment to maintainsinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.Am J Cardiol,1991,68:335-341.
[41]Jung W,Luderitz B.Atrial defibrillation.Z Kardiol,2000,89:206-214.
[42]沈发荣,郑良荣,徐耕,等.现代心脏起搏治疗学.上海科学技术出版社,2004,141.)
[43]Li Renli,Yao Jihua.Analysis of atrial fibrillation after implanation of VVIpacemaker-long-term observation of 154 patients.J Tongji Medicine University,2000,20(2):139-140.
[44]中国中医药学会中医诊断专业委员会.中医病证治法术语.1997.
[45]毛静远,王恒和.心房颤动中医药治疗研究述要.中医学学刊,2003,2(8):1367-1368.
[46]戚文航。心房纤颤机础研究和临床治疗新关点(J).中华心血管杂志,2002,30(10);577
[47]梁金凤贾蕾等。中医辩治冠心病合并阵发性房颤初探。陕西中医,2001,22(8)447-448
[48]伏新顺。复律汤合参麦注射液治疗房颤96例(J).辽宁中医杂志,2000,27(2):71
[49]杨关林,陈民,赵宏阳。应用转律汤辩证治疗房颤120例一附西药对照组60例(J).辽宁中医杂志,2001,21(3):17 178。
[50]谭维富复律汤治疗心房颤动28例(J),湖北中医杂志,2000,2(6):17。
[51]李宜方.中西医结合治疗风心病合并慢性心房颤动20例.山东中医杂志,1996,(6):267.
[52]梁忠.针刺宁心汤并用治疗心房颤动65例.中医函授通讯.2000,19(6):60-64.
[53]杨关林,陈民,赵父月旧.应用转复汤辨证治疗房颤120例一附西药对照组60例.辽宁中医杂志,2001(3):177-178.
[54]曲家珍,陈民,于艳萍.中医药治疗心房颤动的临床研究进展.辽宁中医杂志,1998,2(11):544.
[55]袁云成,傅延林,等.心房颤动的阴阳分类浅析.中医药学刊,2001,19(4):347.
[56]关洪峰。加味炙甘草汤对心力衰竭病发房颤的心律转复疗效观察。中国中医急症,2004,13(2):94
[57]许业辉。生脉散加味治疗老年人心房颤动15例(J)新中医,1998,30(8):62
[58]刘军,高宪虹.定心汤加味治疗快速型心律失常60例[J].上海中医药杂志,2000,34(2):23-24.。
[59]曹崇玉自拟方除颤汤治疗快速型房颤60例(J)安徽中医临床杂志。1999,11(6):395
[60]李平平,段红丽,郭宣誓,等。益气复脉法加胺碘酮治疗老年非瓣膜房颤[J].陕西中医。2006,27(2):154-155。
[61]黄惠芝,范林香.补虚化瘀重镇法为主治疗老年病因不明性房颤.实用医学杂志,1999,15(7):596.
[62]杨发荣.中药转律汤治疗快速房颤32例.辽宁中医杂志,1997,24(2):68.
[63]洪燕.参芪片对老年阵发性孤立性房颤复发的影响.现代中西医结合杂志,2003,12(6):569-571
[64]张苗青.中西医结合治疗冠心病心律失常87例临床疗效观察(J),新中医,1998,(2);21
[65]刘建民.中药抗栓合剂预防房颤复律时栓塞并发症的临床疗效观察,中国中医药信息杂志,2002,9(6):45。
[66]杨志新.心安宁滴鼻剂治疗持续性房颤临床观察.河南中医学院学报,2003,2(1):42-43
[67]张从道,针刺治疗房颤92例。上海中医杂志,1997,6(6):9
[68]张兴凯,张作鹏,冯菁,等.步长稳心颗粒与倍他乐克联合治疗阵发性心房纤颤的临床观察中国临床医药研究杂志,2006,156:18-19
[69]陈平娥.中西医结合治疗冠状动脉粥样硬化性心脏病心房颤动116例临床观察.中西医结合实用临床急救.1999,6(3):124-125.
[70]章平富.中西医结合治疗冠心病初发房颤体会.浙江中西医结合杂志.2002,12(4):242-243.
[71]苑立军,王继军.参麦注射液合胺碘酮治疗老年人冠心病心房颤动.浙江中西医结合杂志,2004,14(7):411-412.
[72]李洪珍等人参根皂贰对不同年龄大鼠单胺类递质含量和MAO活性影响的研究老年学杂志,1989;9(2):114
[73]魏群,周萍.参麦注射液治疗充血性心力衰竭50例中国中西医结合杂志,2000;(10):30
[74]韩铃 陈可冀 黄芪对心血管系统作用的实验药理研究进展中西医结合杂志,2000,20(3):234
[75]高学敏主编中药学人民卫生出版社 2000;(11):922
[76]梅全喜.现代中药药理手册[M].中国中医药出版社(第一版),1998:26-27
[77]陈红.甘草药理作用概述[J].海峡药学 2005;4(17):37-41。
[78]冉瑞明 邵平 参麦注射液治疗病毒性心肌炎107例临床观察临床荟萃,2001:(16):13
[79]李韬,曲德英,雷菠等.三七粉对[家兔实验性动脉粥样硬化的影响[J].中医研究,2006;19(1):17
[80]胡婷 中国生化药物杂志 1993;(1):53
[81]林均明 中国海洋杂志 1991,10(40):23
[82]刘青云.中药药理学[M].人民卫生出版社(第二版),2002:277。
[83]郑有顺.中医血药药理与应用[J].军事医学科学出版社,1999:128。
[84]王彬尧,占振铨,李修阳,等.心脏病治疗学.北京:中国医药科技出版社,2000.44.。
[85]Diringer MN,Kirsch JR,Ladenson PW,et al.Cerebrospinal fluid atrialnatriuretic factor in intracranial disease[J].Stroke,1990,21(11):1550-4.
[86]Nakamura S.Effect of chronic central alpha-hANP administration on blood pressure,water and electrolyte balance in rats[J].Nippon Jinzo Gakkai Shi,1993,35(4):343-347.
[87]Mckay MK,Huxley VH.ANP increases capillary permeability to protein independent of perfusate protein composition[J].Am J Physiol,1995,268(3):1139-1148.
[88]Tanakal.Atrial natriuretic factor in rat hypothalamus,atria and plasma.Detemination by specific radioimmunoassay[J].Biochem Biophys Res Commun,1984,1 24:663-666.
[89]Kawata M.Atrial natriuretic polypeptide:Topographical distribution in the rat brain by radioimmunoassay and immunchistochemistry[J].Neuroscience,1985 16:521-523.
[90]Olivera W,Ridge K,Wood LD,et al.ANF decreases active sodium transport and increases alveolar epithelial permeability in rats[J].Appl Fhysiol,1993,75(4):1581-1586.
[91]Globis S,Frank H,Pacher B,et al.Atrial natriuretic peptide release is more dependent on atrial filling volume than filling pressure in chronic congestive heart failure[J].Am Heart J,1998,135:592-597.
[92]Globis S,FrankH,Pacher B,et al Atrial natriuretic peptide release ismore dependenton atrial filling volume than filling pressure in chronic congestive heart failure[J].Am Heart J,1998,135:592-597.
[93]Verma S,Wang CH,Li SH,et al C-reactive protein attenuates nitric oxide production and inhibits angiogene-sis[J].Circulation,2002,106:913-919.
[94]FumikiY,ToshioN,Yoshikado S,et al Plasma atrial natriuretic peptide concentration inversely correlates with left atrial collagen volume fraction in patients with atrial fibrillation[J].JACC,2002,39:288-294.
[95]张晓文.心房利钠肽与“心”的关系探讨.甘肃中医学院学报,1996;13(2):5-7